XOMA Corp (XOMA):企業の財務・戦略的SWOT分析

◆英語タイトル:XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1406
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

XOMA Corp (XOMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

XOMA Corp (Xoma), formerly Xoma Ltd, is a biopharmaceutical company. It develops antibody-based therapeutics. Its lead product, Gevokizumab is a monoclonal antibody used for the treatment of a wide variety of inflammatory diseases and other diseases. Its other pipeline products include RZ358, XMetA, X213 (formerly LFA 102) and PTH1R. XOMA X358 is a human negative allosteric modulating insulin receptor antibody; X213 is an allosteric inhibitor of prolactin action. Xoma has a developed proprietary antibody platform, optimization and development technologies, comprising ADAPT, ModulX and OptimX. It operates through its subsidiaries in Bermuda, Ireland and the US. Xoma is headquartered in Berkeley, California, the US.

XOMA Corp Key Recent Developments

Mar 10,2020 XOMA reports fourth quarter and full-year 2019 financial results and operating highlights
Nov 05,2019 XOMA reports third quarter 2019 Royalty asset portfolio highlights and financial results
Aug 12,2019 XOMA’s royalty portfolio expands significantly
Aug 06,2019 XOMA reports second quarter 2019 Royalty Asset portfolio highlights and financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
XOMA Corp – Key Facts
XOMA Corp – Key Employees
XOMA Corp – Key Employee Biographies
XOMA Corp – Major Products and Services
XOMA Corp – History
XOMA Corp – Company Statement
XOMA Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
XOMA Corp – Business Description
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
XOMA Corp – Corporate Strategy
XOMA Corp – SWOT Analysis
SWOT Analysis – Overview
XOMA Corp – Strengths
XOMA Corp – Weaknesses
XOMA Corp – Opportunities
XOMA Corp – Threats
XOMA Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
XOMA Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 10, 2020: XOMA reports fourth quarter and full-year 2019 financial results and operating highlights
Nov 05, 2019: XOMA reports third quarter 2019 Royalty asset portfolio highlights and financial results
Aug 12, 2019: XOMA’s royalty portfolio expands significantly
Aug 06, 2019: XOMA reports second quarter 2019 Royalty Asset portfolio highlights and financial results
May 06, 2019: XOMA reports first quarter 2019 financial results and operating highlights
Mar 07, 2019: XOMA reports fourth quarter and full year 2018 financial results and operating highlights
Jan 03, 2019: Xoma names Barbara Kosacz as board director
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
XOMA Corp, Key Facts
XOMA Corp, Key Employees
XOMA Corp, Key Employee Biographies
XOMA Corp, Major Products and Services
XOMA Corp, History
XOMA Corp, Subsidiaries
XOMA Corp, Key Competitors
XOMA Corp, Ratios based on current share price
XOMA Corp, Annual Ratios
XOMA Corp, Annual Ratios (Cont...1)
XOMA Corp, Interim Ratios
XOMA Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
XOMA Corp, Performance Chart (2015 - 2019)
XOMA Corp, Ratio Charts

★海外企業調査レポート[XOMA Corp (XOMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Advantage Oil & Gas Ltd (AAV):石油・ガス:M&Aディール及び事業提携情報
    Summary Advantage Oil & Gas Ltd (Advantage Oil & Gas) is an upstream company. It is involved in exploitation, acquisition, development, and production of crude oil, natural gas and natural gas liquids in Alberta. The company’s exploitation and development program is focused on Glacier assets and the …
  • Cypress Semiconductor Corporation (CY):企業の財務・戦略的SWOT分析
    Cypress Semiconductor Corporation (CY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Ark Restaurants Corp. (ARKR):企業の財務・戦略的SWOT分析
    Ark Restaurants Corp. (ARKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Exonate Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs, which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The company’s alternative mRNA splicing is modulated in disease states that results in the pathologic …
  • Cosucra Groupe Warcoing SA:企業の戦略・SWOT・財務情報
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • PTC India Ltd (PTC):企業の財務・戦略的SWOT分析
    PTC India Ltd (PTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Genentech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • Toppan Printing Co., Ltd.:戦略・SWOT・企業財務分析
    Toppan Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toppan Printing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PTT Public Company Limited:企業の戦略・SWOT・財務情報
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oxford Biodynamics Plc:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • Southwestern Energy Co (SWN):石油・ガス:M&Aディール及び事業提携情報
    Summary Southwestern Energy Co (Southwestern Energy) is an oil and gas company that carries out exploration, development and production of natural gas and crude oil. The company operates through its divisions such as exploration, drilling, completion, production and midstream. Its midstream business …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務分析
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Atrion Corp (ATRI):企業の財務・戦略的SWOT分析
    Atrion Corp (ATRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nobility Homes Inc:企業の戦略的SWOT分析
    Nobility Homes Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析
    Summary Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus Interlong) is a provider of cytokine protein therapeutic drugs and preventive biological products. The company provides products such as recombinant human interferon a-2b for injection, recombinant human interleukin-2 for injection a …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Intas Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropo …
  • Industrial Development Company s.a.l.:企業の戦略・SWOT・財務分析
    Industrial Development Company s.a.l. - Strategy, SWOT and Corporate Finance Report Summary Industrial Development Company s.a.l. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • ARxIUM-医療機器分野:企業M&A・提携分析
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • Bain & Company, Inc.:戦略・SWOT・企業財務分析
    Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bain & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆